Tonix in the News

The National Post | Mar 2, 2017

Canadian synthesizes a better smallpox vaccine - just in case terrorists bring the disease back

Reuters | May 19, 2016

Tonix Pharma PTSD drug shows promise in mid-stage study

Medscape | Nov 17, 2015

New Approach to Fibromyalgia Tackles Poor-Quality Sleep

PharmaVOICE | Nov 16, 2015

21st Century Cures Act

BioPharma Dive | Oct 8, 2015

An innovation challenge: Using pharma R&D as a tool for social change

Life Science Leader | Jul 1, 2015

Companies to Watch: Tonix Pharmaceuticals

Bioworld Today | May 14, 2015

Lead ‘tonic’ for Tonix targets fibromyalgia in phase III study

Fibromyalgia News Today | May 14, 2015

Tonix Pharmaceuticals Launches Phase 3 Clinical Trial To Evaluate Experimental Fibromyalgia Therapy

Pain.com | May 13, 2015

Sleep and Pain in Fibromyalgia

The Medicine Maker | May 5, 2015

The Big Leap from Academic to Entrepreneur

Clinical Pain Advisor | Mar 26, 2015

Better Sleep, Less Pain: Studying the Links

Daily News | Nov 11, 2014

Long battles remain for veterans suffering from PTSD

DDD Magazine | Aug 27, 2014

A ‘Second Revolution’ in Drug Discovery and Development

Life Science Leader | Jul 1, 2014

The Evolving Role Of Drug Mechanism Of Action In Drug Discovery And Development

Fibro & Fabulous | Jun 23, 2014

Interview with Dr. Seth Lederman CEO of Tonix Pharmaceuticals

MedCity News | Jun 23, 2014

Tonix Pharmaceuticals developing treatment for underserved PTSD patients

Drug Delivery & Development | Jun 11, 2014

Tonix Gets IND Clearance from FDA for PTSD Treatment

Fierce Pharma | Jun 10, 2014

Tonix receives IND approval for sublingual formulation to treat PTSD

Fierce Pharma | May 13, 2014

Tonix's sublingual formulation for fibromyalgia reaches pivotal trial stage

National Pain Report | Apr 23, 2014

Tonix is enrolling participants in a Phase 3 trial for fibromyalgia, the RESILIENT study. For more information, please visit www.resilientstudy.com or www.clinicaltrials.gov (NCT05273749).

Tonix in the News

Canadian synthesizes a better smallpox vaccine - just in case terrorists bring the disease back

Tonix Pharma PTSD drug shows promise in mid-stage study

New Approach to Fibromyalgia Tackles Poor-Quality Sleep

21st Century Cures Act

An innovation challenge: Using pharma R&D as a tool for social change

Companies to Watch: Tonix Pharmaceuticals

Lead ‘tonic’ for Tonix targets fibromyalgia in phase III study

Tonix Pharmaceuticals Launches Phase 3 Clinical Trial To Evaluate Experimental Fibromyalgia Therapy

Sleep and Pain in Fibromyalgia

The Big Leap from Academic to Entrepreneur

Better Sleep, Less Pain: Studying the Links

Long battles remain for veterans suffering from PTSD

A ‘Second Revolution’ in Drug Discovery and Development

The Evolving Role Of Drug Mechanism Of Action In Drug Discovery And Development

Interview with Dr. Seth Lederman CEO of Tonix Pharmaceuticals

Tonix Pharmaceuticals developing treatment for underserved PTSD patients

Tonix Gets IND Clearance from FDA for PTSD Treatment

Tonix receives IND approval for sublingual formulation to treat PTSD

Tonix's sublingual formulation for fibromyalgia reaches pivotal trial stage

Fibromyalgia Drugs: Successes or Failures?